Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Cerebrus develops novel animal satiety model

Aug. 22, 1997

Non-parenteral insulin formulations for treating IDDM

Aug. 21, 1997

U.S. patent allowed for erectile dysfunction therapy

Aug. 21, 1997

Phase IV trial of Redux

Aug. 21, 1997

Squalene synthase inhibitors in development at Sankyo

Aug. 21, 1997

Antidiabetic herbomineral formulation tested in Indian patients

Aug. 20, 1997

Rapid-acting insulin analog under clinical evaluation

Aug. 20, 1997

Imidazoline derivative displays potent antidiabetic effects in rats

Aug. 20, 1997

DPP-IV inhibition in the treatment of diabetes

Aug. 20, 1997

Repaglinide gets expedited review status in U.S

Aug. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...